Hematology FISH Probe Protocol
For Cytocell AML and MDS FISH Probe Kits only
Watch our brilliant Field Application Specialist, Gothami Fonseka, demonstrate the fluorescence in situ hybridization (FISH) protocol for use with OGT's Cytocell® range of FDA-cleared Class II IVD FISH probe test kits for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Either watch the protocol in full or choose a specifc step of the protocol.
Full Hematology FISH Probe Protocol
For use with Cytocell AML and MDS FISH Probe Kits only
Watch the full hematology FISH probe protocol from start to finish.
Step 1. Sample Preparation
For use with Cytocell AML and MDS FISH Probe Kits only
Watch our video for the sample preparation step of the hematology FISH probe protocol.
Step 2. Probe Application
For use with Cytocell AML and MDS FISH Probe Kits only
Watch our video for the probe application step of the hematology FISH probe protocol.
Step 3. Denaturation and Hybridization
For use with Cytocell AML and MDS FISH Probe Kits only
Watch our video for the denaturation and hybridization step of the hematology FISH probe protocol.
Step 4. Post-Hybridization Washes
For use with Cytocell AML and MDS FISH Probe Kits only
Watch our video for the post-hybridization wash step of the hematology FISH probe protocol.
Step 5. Counterstain and Analysis
For use with Cytocell AML and MDS FISH Probe Kits only
Watch our video for the counterstain and analysis step of the hematology FISH probe protocol.
Disclaimer
Study the Package Insert (Instructions for Use, IFU) carefully before using the protocol depicted in this video. This video does not replace the content from the Package Insert.
The Package Insert can be found in the product packaging of each FISH Probe Kit and by using the Resources section of the Cytocell website (www.cytocell-us.com/resources).
Refer to the Package Insert for warnings, precautions, storage and handling.
The Cytocell Aquarius AML/MDS range of FISH probe test kits are fluorescence in situ hybridization (FISH) tests used to detect common chromosomal rearrangements in fixed bone marrow specimens from patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The tests are indicated for the characterization of patient specimens consistent with World Health Organization guidelines for Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th Edition) and in conjunction with other clinicopathological criteria. The assay results are to be interpreted by a qualified pathologist or cytogeneticist. The tests are not intended for use as a stand-alone diagnostic, disease screening, or as a companion diagnostic.
Refer to individual test kit Package Insert for the specific intended use and limitations.
For In Vitro Diagnostic Use. Rx only.
For sale in the US only. This product has not been licensed in accordance with Canadian law.
This webpage and its contents are © Oxford Gene Technology IP Limited – 2020. All rights reserved.
Trademarks: OGT™ (Oxford Gene Technology IP Ltd); Cytocell®; Aquarius® (Cytocell Ltd).